A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...
A prospective case-control study of 150 participants found circulating cell-free DNA distinguished ovarian cancer from benign ...
Please provide your email address to receive an email when new articles are posted on . Cell-free fetal antigen analyses had 100% consistency for 465 calls on antigens in which women were ...
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
Analyzing tumor DNA in cerebrospinal fluid could provide valuable diagnostic information when MRI results are unclear or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results